The Valley Desk

NCT02631876 · Interventional trial

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer

Overall registry status Completed

Phase 3

Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov